相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era
Irit Avivi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma
Tae Min Kim et al.
CANCER (2013)
Diffuse large B-cell lymphoma
Maurizio Martelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Epidemiology of lymphoid malignancies: last decade update
Silvana Novelli et al.
SPRINGERPLUS (2013)
The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma
Silvia Park et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
SUV on Dual-Phase FDG PET/CT Correlates With the Ki-67 Proliferation Index in Patients With Newly Diagnosed Non-Hodgkin Lymphoma
Chin-Chuan Chang et al.
CLINICAL NUCLEAR MEDICINE (2012)
Positron Emission Tomographic Scans in Lymphoma: Convention and Controversy
Stephen M. Ansell et al.
MAYO CLINIC PROCEEDINGS (2012)
Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma
Tomas Papajik et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
Dai Chihara et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma
Giovanni Storto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma
Reina Watanabe et al.
LEUKEMIA & LYMPHOMA (2010)
FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease
Fabio M. Paes et al.
RADIOGRAPHICS (2010)
Assessment of Metabolic Response to Radioimmunotherapy with Y-90-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Giovanni Storto et al.
RADIOLOGY (2010)
High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma
J. Y. Y. Ngeow et al.
ANNALS OF ONCOLOGY (2009)
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
Heinz-Wolfram Bernd et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Correlating Metabolic Activity with Cellular Proliferation in Follicular Lymphomas
Bingfeng Tang et al.
MOLECULAR IMAGING AND BIOLOGY (2009)
Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma
Maria Christina Cox et al.
LEUKEMIA & LYMPHOMA (2008)
The role of FDG-PET scans in patients with lymphoma
Pamela Seam et al.
BLOOD (2007)
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
Laurie H. Sehn et al.
BLOOD (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake
Martin Hutchings et al.
HEMATOLOGICAL ONCOLOGY (2006)
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
Thomas M. Habermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma:: an early prognostic tool for predicting patient outcome
C Haioun et al.
BLOOD (2005)
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma:: prevalence and scan interpretation
P Castellucci et al.
NUCLEAR MEDICINE COMMUNICATIONS (2005)
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma
H Schöder et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma
R Naumann et al.
BRITISH JOURNAL OF CANCER (2004)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT
NG Mikhaeel et al.
LEUKEMIA & LYMPHOMA (2000)
分享论文
